Mary C. Tanner

Mary C. Tanner
Born (1951-10-10) October 10, 1951 (age 73)
Alma materHarvard University
SpouseFrederick Frank[1][2][3]
Scientific career
FieldsInvestment banking, biotechnology
InstitutionsEVOLUTION Life Science Partners, Peter J. Solomon Company, Lehman Brothers

Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services.[4][5] Her expertise includes ethical pharmaceuticals and green technology.[1] Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments.[4][5]

As of 2014, Tanner was Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP. Previously she served as Senior Managing Director of Lehman Brothers, Bear Stearns, and the Peter J. Solomon Company.[4][5] Tanner was the first woman to become a partner at Lehman Brothers.[6] She is credited with directing over 130 IPOs for life sciences organizations,[5] and over 500 mergers and acquisitions.[4]

  1. ^ a b "Advisory Council : Mary Tanner". LifeSciNYC. Retrieved 14 May 2019.
  2. ^ Abkowitz, Alyssa (March 20, 2009). "Health care's dealmaking couple is back Frank and Tanner, the first family of pharma finance, are together again in time for the industry's wave of consolidation". Fortune. Retrieved 14 May 2019.
  3. ^ "Mary C. Tanner Becomes a Bride". The New York Times. October 16, 1988. Retrieved 14 May 2019.
  4. ^ a b c d "Presented by Yale Office of Cooperative Researchand Yale Entrepreneurial Institute Connecting Innovators and Investors at Yale" (PDF). Yale Innovation Summit. 2017. Retrieved 17 May 2019.
  5. ^ a b c d Cite error: The named reference Tidmarsh was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference Bloomberg was invoked but never defined (see the help page).